vasopeptidase inhibitor

Omapatrilat      

pathologytreatmentpatient Demonstrated benefit and harm k      
heart failureomapatrilatnot classified

versus angiotensin-converting enzyme inhibitors

No demonstrated result for efficacy

2 trialsmeta-analysis